Combination therapy comprising the use of ET-743 and paclitaxel for treating cancer

Details for Australian Patent Application No. 2004291037 (hide)

Owner Pharma Mar, S.A.

Inventors Rowinsky, Eric Keith; Chu, Quincy SiuChung; Lazaro, Luis Lopez; Donaque, Jose Maria Jimeno

Agent Griffith Hack

Pub. Number AU-A-2004291037

PCT Pub. Number WO2005/049030

Priority 60/520,330 14.11.03 US

Filing date 28 October 2004

Wipo publication date 2 June 2005

International Classifications

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

25 May 2006 PCT application entered the National Phase

  PCT publication WO2005/049030 Priority application(s): WO2005/049030

26 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004291040-System and method for transdermal delivery

2004291030-Preventative effects of morinda citrifolia on mammary breast cancer